Drug Development
The antibodies are specific for daratumumab and inhibit the binding of the drug to CD38
| 1 min read
An analysis method for protein–protein interactions using proximity-dependent biotinylation for next-generation drugs
| 2 min read
Metformin highly effective in targeting diabetes and some cancers, but potentially dangerous with others
| 2 min read
Join Lab Manager and our panel of experts as we discuss a study that highlights the measuring potential of synergistic effects of combination therapy using matrix screensAvailable on Demand
Bio-Rad Laboratories launches four inhibitory antibodies that are highly specific to pertuzumab
| 1 min read
Twisted semiconductor nanostructures convert red light into twisted blue light in tiny volumes
| 3 min read
Researchers demonstrate “V-SYNTHES,” a virtual method of sifting through “molecular puzzle pieces”
| 4 min read
Scientists use a technique called “targetable reactive electrophiles and oxidants,” or T-REX for short, to study reactive electrophiles
| 2 min read
Surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials
| 3 min read
